SCHEMBL8097341

SCHEMBL8097341

O=C(O)C1CCCN1C(=O)COCCOCCOCC(=O)N1CCCC1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MVD P53602 2/20 0.57
▸ ACE P12821 10/20 0.55
▸ ACE2 Q9BYF1 2/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ REN P00797 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ F2 P00734 1/20 0.45
▸ LTA4H P09960 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ PEPD P12955 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ PTGS1 P23219 1/20 0.45
▸ HTR2A P28223 1/20 0.45
▸ PTGS2 P35354 1/20 0.45
▸ HRH1 P35367 1/20 0.45
▸ THPO P40225 1/20 0.45
▸ PMP22 Q01453 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6786825 1.00 MVD (0.57) MVDACEACE2RAB9AREN
SCHEMBL4867627 0.81 MVD (0.58) MVDACEACE2RAB9AREN
SCHEMBL2607303 0.81 MVD (0.58) MVDACEACE2RAB9AREN
SCHEMBL31694871 0.81 MVD (0.58) MVDACEACE2RAB9AREN
SCHEMBL7710658 0.79 DPP4 (0.45) MVDACE
SCHEMBL6782701 0.78 ACE (0.72) MVDACEREN
SCHEMBL6782705 0.78 ACE (0.72) MVDACEREN
SCHEMBL5742919 0.78 ACE (0.61) MVDACEACE2LTA4HALDH1A1
SCHEMBL5742925 0.78 ACE (0.61) MVDACEACE2LTA4HALDH1A1
SCHEMBL1537428 0.77 ACE (0.64) MVDACEACE2RAB9AREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103910-A FOR TREATMENT OF DISEASES ASSOCIATED WITH AMYLOIDOSIS, SUCH AS ALZHEIMER'S DISEASE, DIABETES MELLITUS, FAMILIAL AMYLOID POLYNEUROPATHY, SCRAPIE, AND KREUZFELD-JACOB DISEASE HOFFMANN-LA ROCHE INC. (US) 2000-08-15 — — US disclosed
Send feedback